This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Biogen (BIIB) and Omada Health, Inc. (OMDA)

Tipranks - Tipranks - Tue Jun 23, 8:02AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biogen (BIIB) and Omada Health, Inc. (OMDA) with bullish sentiments.

TipRanks' Prime Week Sale - 70% Off

Biogen (BIIB)

Biogen received a Buy rating and a $206.00 price target from Cantor Fitzgerald analyst Eric Schmidt FCA today. The company’s shares closed last Thursday at $196.58.

According to TipRanks.com, FCA is ranked #308 out of 12315 analysts.

Currently, the analyst consensus on Biogen is a Moderate Buy with an average price target of $224.50, implying a 12.1% upside from current levels. In a report issued on June 8, Needham also upgraded the stock to Buy with a $255.00 price target.

See the top stocks recommended by analysts >>

Omada Health, Inc. (OMDA)

In a report released today, Craig Hettenbach from Morgan Stanley reiterated a Buy rating on Omada Health, Inc., with a price target of $30.00. The company’s shares closed last Thursday at $17.64.

Hettenbach has an average return of 4.8% when recommending Omada Health, Inc.. ;'>

According to TipRanks.com, Hettenbach is ranked #2201 out of 12315 analysts.

Omada Health, Inc. has an analyst consensus of Strong Buy, with a price target consensus of $22.89, representing a 32.3% upside. In a report issued on June 10, Goldman Sachs also maintained a Buy rating on the stock with a $25.00 price target.

Read More on BIIB:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).